MAP2K1 and non-small cell lung carcinoma: To examine the effect of PC and U0126 (a specific MEK1/2 inhibitor) on cellular migration and invasion activity in NSCLC cells, we subjected human A549 cells to treatments of PC (0 and 20 μM) and/or U0126 (0 and 20 μM) for 24 h.